# Development and Qualification of Methods for Analyzing the Mucosal Immune Response to COVID-19

> **NCT06142279** · NA · UNKNOWN · sponsor: **University Hospital, Tours** · enrollment: 240 (estimated)

## Conditions studied

- Certain Disorders Involving the Immune Mechanism

## Interventions

- **BIOLOGICAL:** Sampling
- **BIOLOGICAL:** PCR (polymerase chain reaction) SARS-CoV-2

## Key facts

- **NCT ID:** NCT06142279
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11
- **Primary completion:** 2024-11
- **Final completion:** 2024-11
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2023-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06142279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06142279, "Development and Qualification of Methods for Analyzing the Mucosal Immune Response to COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06142279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*